Published On: Wed, Oct 19th, 2016

Recently Changed Price Targets On Medgenics, Inc. (MDGN)


A number of investment brokers have recently updated their price targets on shares of Medgenics, Inc. (MDGN).

Most recent broker ratings

09/23/2016 – Jefferies began new coverage on Medgenics, Inc. giving the company a “buy” rating. They now have a USD 10 price target on the stock.

06/07/2016 – Medgenics, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 12 price target on the stock.

01/20/2015 – Medgenics, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 11.5 price target on the stock.

The share price of Medgenics, Inc. (MDGN) was down -1.92% during the last trading session, with a day high of 5.35. 99299 shares were traded on Medgenics, Inc.’s last session.

The stock’s 50 day moving average is 5.35 and its 200 day moving average is 5.47. The stock’s market capitalization is 189.10M. Medgenics, Inc. has a 52-week low of 3.09 and a 52-week high of 7.57.